HIV, AIDS and the cardiovascular risk;HIV, AIDS und kardiovaskuläres risiko

Internist

Volumn 49, Issue 4, 2008, Pages 429-435

  Neumann, T ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

AIDS; Antiretroviral therapy; Cardiovascular risk factors; Heart failure; HIV Infection

Indexed keywords

ALPHA INTERFERON; DOXORUBICIN; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTERIOSCLEROSIS; CARDIOVASCULAR RISK; CHRONIC DISEASE; CONGESTIVE CARDIOMYOPATHY; COR PULMONALE; GLUCOSE METABOLISM; HEART DISEASE; HEART FAILURE; HEART MUSCLE NECROSIS; HEART TAMPONADE; HIV ASSOCIATED LIPODYSTROPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; KAPOSI SARCOMA; LYMPHOMA; MORBIDITY; MORTALITY; MYOCARDITIS; OPPORTUNISTIC INFECTION; PERICARDITIS; REVIEW; SMOKING; VASCULITIS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-HIV AGENTS; CARDIOMYOPATHIES; CARDIOVASCULAR DISEASES; HEART FAILURE; HIV INFECTIONS; HUMANS; RISK FACTORS; SURVIVAL RATE;

EID: 41149103817     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00108-008-2049-4     Document Type: Review

References (24)

1. Barbaro G (2002) Cardiovascular manifestations of HIV infection. Circulation, 106: 1420-1425
2. Barre-Sinoussi F, Chermann JC, Rey F et al. (1983) Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 220: 868-871
3. Behrens G, Dejam A, Schmidt H et al. (1999) Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors. AIDS 13: F63-F70
4. Chen F, Shannon K, Ding S et al. (2002) HIV type 1 glycoprotein 120 inhibits cardiac myocyte contraction. AIDS Res Hum Retroviruses 18: 777-784
5. Crum NF, Riffenburgh RH, Wegener S et al. (2006) Comparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras. J Acquir Immune Defic Syndr 41: 194-200
6. Currie PF, Jacob AJ, Foreman AR et al. (1994) Heart muscle disease related to HIV-infection: prognostic implications. BMJ 309: 1605-1607
7. Felker GM, Thompson RE, Hare JM et al. (2000) Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 342: 1077-1084
8. Fisher SD, Lipshultz SE (2001) Cardiovascular abnormalities in HIV-infected individuals. In: Braunwald E (ed) Heart disease: a text book of cardiovascular medicine. Saunders, Philadelphia, p 2211-2221
9. Friis-Moller N, Sabin CA, Weber R et al. (2003) Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med 349: 1993-2003
10. Grody WW, Cheng L, Lewis W (1990) Infection of the heart by the human immunodeficiency virus. Am J Cardiol 66: 203-206
11. Hoffmann C (2005) Vorzeitige Arteriosklerose bei HIV-infizierten Patienten? Aktueller Stand. Herz 30: 467-471
12. Neumann T, Miller M, Esser S et al. (2002) Arteriosklerose bei HIV-positiven Patienten. Z Kardiol 91: 879-888
13. Neumann T, Ross B, Hengge UR et al. (2002) Kardiale Manifestationen der HIV-Infektion. Med Klin 97: 659-665
14. Neumann T, Woiwod T, Neumann A et al. (2004) Cardiovascular risk factors and probability of cardiovascular events in HIV-infected patients: Part III: Age Differences. Eur J Med Res 9: 267-672
15. Neumann T, Woiwod T, Neumann A et al. (2004) Cardiovascular risk factors and probability of cardiovascular events in HIV-infected patients: Part II: Gender differences. Eur J Med Res 955-960
16. Patel RC, Frishman WH (1996) Cardiac involvement in HIV infection. Med Clin North Am 80: 1493-1512
17. Raidel SM, Haase C, Jansen NR et al. (2002) Targeted myocardial transgenic expression of HIV Tat causes cardiomyopathy and mitochondrial damage. Am J Physiol Heart Circ Physiol 282: H1672-H1678
18. Robert Koch-Institut (2006) Epidemiologisches Bulletin http://www.rki.de
19. Roy VP, Prabhakar S, Pulvirenti J et al. (1999) Frequency and factors associated with cardiomyopathy in patients with human immunodeficiency virus infection in an inner-city hospital. J Natl Med Assoc 91: 502-504
20. Sullivan AK, Nelson MR (1997) Marked hyperlipidaemia on ritonavir therapy. AIDS 11: 938-939
21. Sundstrom JB, Mosunjac M, Martinson DE (2001) Effects of norepinephrine, HIV type 1 infection, and leukocyte interactions with endothelial cells on the expression of matrix metalloproteinases. AIDS Res Hum Retroviruses 17: 1605-1614
22. UNAIDS/WHO (2007) AIDS-Epidemic Update, WHO http://www.who.org
23. Wu TC, Pizzorno MC, Hayward GS et al. (1992) In situ detection of human cytomegalovirus immediate-early gene transcript within cardiac myocytes of patients with HIV-associated cardiomyopathy. AIDS 6: 777-785
24. Zazzo JF, Chalas J, Lafont A (1988) Is nonobstructive cardiomyopathy in AIDS a selenium deficiency-related disease? JPEN J Parenter Enteral Nutr 12: 537-538